External Validation of the ImAgeS Risk Score for Mortality in Hospitalized Kidney Transplant Recipients with COVID-19: A Retrospective Observational Study
Background: Timely recognition of high-risk individuals with novel Coronavirus disease (COVID-19) is important. Yet, validated risk scores for kidney transplant recipients with COVID-19 are lacking. The present study aimed to externally validate the novel ImAgeS risk score in this population. Method...
Main Authors: | Josipa Domjanović, Tea Domjanović Škopinić, Tea Gamberažić Kirevski, Andrija Matetic |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-04-01
|
Series: | BioMed |
Subjects: | |
Online Access: | https://www.mdpi.com/2673-8430/3/2/18 |
Similar Items
-
Association of Different Risk Scores and 30-Day Mortality in Kidney Transplant Recipients with COVID-19
by: Josipa Domjanović, et al.
Published: (2023-03-01) -
Performance of Derived Laboratory Biomarkers with Regard to 30-Day Mortality in Kidney Transplant Recipients with COVID-19
by: Josipa Domjanović, et al.
Published: (2022-12-01) -
Neurologic Biomarkers, Neuroimaging, and Cognitive Function in Persistent Atrial Fibrillation: A Cross-Sectional Study
by: Josip Kedžo, et al.
Published: (2023-02-01) -
Renal cancer in recipients of kidney transplant
by: Prajwal Dhakal, et al.
Published: (2017-03-01) -
Immunologic monitoring in kidney transplant recipients
by: Natavudh Townamchai, et al.
Published: (2013-06-01)